ADVANCE infectious diseases pharmacy through collaboration, research and education and LEAD antimicrobial stewardship to OPTIMIZE the care of patients with infections in every practice setting
Grant Funding secured from Pfizer for first SIDP research program
Industry began to see ID pharmacists as persons of influence
1995–1996
John Rotschafer, PharmD, FCCP
1996–1997
Steven Barriere, PharmD, FIDSA, FCCP, FIDP
1997–1998
Joseph Bertino, PharmD, FCP, FCCP
At a time when the role of the ID pharmacist was often questioned, we advocated for the ability of ID pharmacists to make drug recommendations in a series of letters in CID. We then continued conversations with IDSA leadership in a face-to-face meeting that led to better cooperation and understanding from both sides
SIDP along with ACCP and ASHP responds to statement from IDSA on the role of pharmacists in infectious disease
1998–1999
James Garrelts, PharmD, FASHP
SIDP invited to participate in a national summit with several other societies to develop national guidelines
The great camaraderie within the ID pharmacist community has resulted in the growth and success of our organization
1999–2000
Robert Stevens, PharmD, FCCP
ID Pharmacy Residency Awards program expanded
SIDP members recommended to guideline panels, FDA Anti-Infective and Anti-Viral Drug Advisory Committees and the CDC Interagency Task Force on Antimicrobial Resistance
2000–2001
Peggy Carver, PharmD, FCCP, FIDP
SIDP and ICAAC are postponed due to the events of September 11, 2001
2001–2002
Charles Ballow, PharmD, FCCP
2002–2003
Michael Rybak, PharmD, MPH, PhD, FCCP, FIDSA, FIDP
(@IDpharmresearch)
Expanding our visibility by collaborating with other professional societies and co-sponsoring 10 educational/research programs with IDSA_ICAAC, SHEA, ACCP and MAD-ID
SIDP was represented in two therapeutic guideline initiatives
SIDP was invited to take part in an antimicrobial resistance task force in Washington, DC hosted by Richard Wenzel, MD and Ron Polk, Pharm.D. along with representatives from IDSA, CDC, SIS, ACCP, SHEA and others
SIDP co-sponsored a press conference at the New York Academy of Sciences in New York City on antimicrobial resistance which resulted in over 30 citations for SIDP’s active role in journals, newspapers and medical websites
Established a formal relationship with the journal Pharmacotherapy to include a new ID therapeutic section called “Insights from SIDP” where SIDP member authored reviews and research papers could be published under this banner
Development of a new interactive SIDP website that included SIDP events, news, member search functions, committee reports, the society’s newsletter and an interactive listserver
Established the SIDP/Pfizer Fellowship Award Program
2003–2004
Douglas Fish, PharmD, FCCM, FCCP, BCCCP, BCPS (AQ-ID), FIDP
SIDP Passed the 350-member mark
SIDP played a key role in developing qualifications for the brand-new but very important Added Qualifications in Infectious Diseases (AQ-ID) designation by BPS
HIV section created
First year for online membership applications/renewals and electronic voting for elections
2004–2005
Steven Ebert, PharmD, FCCP, FIDSA, BCIDP
Emphasis shift from industry-sponsored events to collaboration with public health organizations
Greater delegation to committees and member-driven activities and less reliance on Board of Directors
Increased focus on/support of the beneficial impacts of pharmacist-driven antimicrobial stewardship
2015 invitation to the White House Forum on Antibiotic Stewardship
Expanding national advocacy presence
Expansion of the Antimicrobial Stewardship Certificate Program
2015–2016
Jason Gallagher, PharmD, FCCP, FIDSA, BCPS, FIDP
(@JGPharmD)
Creation of SIDPEC
Creation of Long-Term Care (LTC) Antimicrobial Stewardship Certificate Program
SIDP logo modernized
2016–2017
Melinda Neuhauser, PharmD, MPH, FCCP, FASHP, FIDP
First SIDP Annual Meeting in conjunction with IDWeekTM with the inaugural induction of Fellowship of SIDP (FIDP)
Initiated strategic planning to serve as the foundation for SIDP’s future internal and external growth to enhance our organizational structure, efficiency, communication, and impact
Completed comprehensive financial audit with plan to incorporate into organization structure
Competitive re-bid of management company contract that led to switching from EAMI to Affinity Strategies
2017–2018
Elizabeth Dodds Ashley, PharmD, MHS, FCCP, FIDP, BCPS
(@The_Real_LDA)
Launched the year with updated strategic plan and the shared vision of safe and effective antimicrobials for now and the future
SIDP joined as a supporter of Global AMR challenge solidifying the organization's role on the international stage
Joined with our new management company (Affinity Strategies)
SIDP members showed dedication, commitment, and expertise to the global community to help ensure that [patients were optimally managed, and that the public was informed as it related to the latest on the prevention and treatment of this devastating disease.
SIDP members created and constantly updated educational content for the management of COVID-19
Members were stretched incredibly thin by increasing demands in their day to day practice, but still willingly put in extra time and effort to give back to the Society